North America Rabeprazole Sodium Market Size, Share & Trends Analysis Report By Age, By Distribution Channel (Drug & Retail Store Pharmacies, Hospital Pharmacies and Online Pharmacies), By Application, By Country and Growth Forecast, 2024 - 2031

PUBLISHED: June 28, 2024

PAGES: 86 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

List of Tables

The North America Rabeprazole Sodium Market would witness market growth of 3.1% CAGR during the forecast period (2024-2031).

The US market dominated the North America Rabeprazole Sodium Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $233,909.5 Thousands by 2031. The Canada market is experiencing a CAGR of 5.3% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 4.4% during (2024 - 2031).

Rabeprazole sodium is a proton pump inhibitor (PPI) medication that is predominantly indicated for the treatment of a variety of acid-related gastrointestinal disorders by reducing stomach acid production. PPI is a class of medications that function by permanently suppressing the enzyme system (the proton pump), which is responsible for the ultimate stage of acid production in the stomach lining.

Additionally, within the pharmaceutical industry, the market is a critical segment that is dedicated to the treatment of gastrointestinal disorders, with a particular emphasis on those that are associated with excessive gastric acid production.

In North America, the increasing demand for it is fueled by the rising prevalence of gastrointestinal disorders. According to the National Library of Medicine, the estimated prevalence of GERD in the US is between 18.1% and 27.8%. The prevalence of GERD is slightly higher in men than in women. This substantial patient base creates a significant market for effective treatments like rabeprazole sodium.

Based on Age, the market is segmented into Below 55 years and Above 55 years. Based on Distribution Channel, the market is segmented into Drug & Retail Store Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on Application, the market is segmented into Gastroesophageal Reflux Disease, Peptic Ulcer and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Cipla Limited
Sun Pharmaceutical Industries Ltd.
Intas Pharmaceuticals Ltd.
Dr. Reddy's Laboratories Ltd.
Cadila Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd
Woodward Pharma
Elikem Pharmaceuticals Pvt Ltd
Jasco Labs Private Limited
Torrent Pharmaceuticals Ltd.

North America Rabeprazole Sodium Market Report Segmentation

By Age

Below 55 years and
Above 55 years

By Distribution Channel

Drug & Retail Store Pharmacies,
Hospital Pharmacies and
Online Pharmacies

By Application

Gastroesophageal Reflux Disease,
Peptic Ulcer and
Others

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Rabeprazole Sodium Market, by Age
- 1.4.2 North America Rabeprazole Sodium Market, by Distribution Channel
- 1.4.3 North America Rabeprazole Sodium Market, by Application
- 1.4.4 North America Rabeprazole Sodium Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Rabeprazole Sodium Market by Age

4.1 North America Below 55 years Market by Country
4.2 North America Above 55 years Market by Country

Chapter 5. North America Rabeprazole Sodium Market by Distribution Channel

5.1 North America Drug & Retail Store Pharmacies Market by Country
5.2 North America Hospital Pharmacies Market by Country
5.3 North America Online Pharmacies Market by Country

Chapter 6. North America Rabeprazole Sodium Market by Application

6.1 North America Gastroesophageal Reflux Disease Market by Country
6.2 North America Peptic Ulcer Market by Country
6.3 North America Others Market by Country

Chapter 7. North America Rabeprazole Sodium Market by Country

7.1 US Rabeprazole Sodium Market
- 7.1.1 US Rabeprazole Sodium Market by Age
- 7.1.2 US Rabeprazole Sodium Market by Distribution Channel
- 7.1.3 US Rabeprazole Sodium Market by Application
7.2 Canada Rabeprazole Sodium Market
- 7.2.1 Canada Rabeprazole Sodium Market by Age
- 7.2.2 Canada Rabeprazole Sodium Market by Distribution Channel
- 7.2.3 Canada Rabeprazole Sodium Market by Application
7.3 Mexico Rabeprazole Sodium Market
- 7.3.1 Mexico Rabeprazole Sodium Market by Age
- 7.3.2 Mexico Rabeprazole Sodium Market by Distribution Channel
- 7.3.3 Mexico Rabeprazole Sodium Market by Application
7.4 Rest of North America Rabeprazole Sodium Market
- 7.4.1 Rest of North America Rabeprazole Sodium Market by Age
- 7.4.2 Rest of North America Rabeprazole Sodium Market by Distribution Channel
- 7.4.3 Rest of North America Rabeprazole Sodium Market by Application

Chapter 8. Company Profiles

8.1 Cadila Pharmaceutical Limited
- 8.1.1 Company Overview
8.2 Alembic Pharmaceuticals Ltd. (Alembic Group)
- 8.2.1 Company Overview
8.3 Woodward Pharma Services
- 8.3.1 Company Overview
8.4 Elikem Pharmaceuticals Pvt. Ltd.
- 8.4.1 Company Overview
8.5 Jasco Labs Pvt Ltd
- 8.5.1 Company Overview
8.6 Torrent Pharmaceuticals Ltd.
- 8.6.1 Company Overview
8.7 Cipla Limited
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expense
- 8.7.5 SWOT Analysis
8.8 Sun Pharmaceutical Industries Ltd.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Regional Analysis
- 8.8.4 Research & Development Expenses
- 8.8.5 SWOT Analysis
8.9 Intas Pharmaceutical Ltd.
- 8.9.1 Company Overview
8.10. Dr. Reddy's Laboratories Ltd.
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Segmental and Regional Analysis
- 8.10.4 Research & Development Expense
- 8.10.5 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 2 North America Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 3 North America Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 4 North America Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 5 North America Below 55 years Market by Country, 2020 - 2023, USD Thousands
TABLE 6 North America Below 55 years Market by Country, 2024 - 2031, USD Thousands
TABLE 7 North America Above 55 years Market by Country, 2020 - 2023, USD Thousands
TABLE 8 North America Above 55 years Market by Country, 2024 - 2031, USD Thousands
TABLE 9 North America Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 10 North America Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 11 North America Drug & Retail Store Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 12 North America Drug & Retail Store Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 13 North America Hospital Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 14 North America Hospital Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 15 North America Online Pharmacies Market by Country, 2020 - 2023, USD Thousands
TABLE 16 North America Online Pharmacies Market by Country, 2024 - 2031, USD Thousands
TABLE 17 North America Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 18 North America Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 19 North America Gastroesophageal Reflux Disease Market by Country, 2020 - 2023, USD Thousands
TABLE 20 North America Gastroesophageal Reflux Disease Market by Country, 2024 - 2031, USD Thousands
TABLE 21 North America Peptic Ulcer Market by Country, 2020 - 2023, USD Thousands
TABLE 22 North America Peptic Ulcer Market by Country, 2024 - 2031, USD Thousands
TABLE 23 North America Others Market by Country, 2020 - 2023, USD Thousands
TABLE 24 North America Others Market by Country, 2024 - 2031, USD Thousands
TABLE 25 North America Rabeprazole Sodium Market by Country, 2020 - 2023, USD Thousands
TABLE 26 North America Rabeprazole Sodium Market by Country, 2024 - 2031, USD Thousands
TABLE 27 US Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 28 US Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 29 US Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 30 US Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 31 US Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 32 US Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 33 US Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 34 US Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 35 Canada Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 36 Canada Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 37 Canada Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 38 Canada Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 39 Canada Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 40 Canada Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 41 Canada Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 42 Canada Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 43 Mexico Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 44 Mexico Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 45 Mexico Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 46 Mexico Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 47 Mexico Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 48 Mexico Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 49 Mexico Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 50 Mexico Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 51 Rest of North America Rabeprazole Sodium Market, 2020 - 2023, USD Thousands
TABLE 52 Rest of North America Rabeprazole Sodium Market, 2024 - 2031, USD Thousands
TABLE 53 Rest of North America Rabeprazole Sodium Market by Age, 2020 - 2023, USD Thousands
TABLE 54 Rest of North America Rabeprazole Sodium Market by Age, 2024 - 2031, USD Thousands
TABLE 55 Rest of North America Rabeprazole Sodium Market by Distribution Channel, 2020 - 2023, USD Thousands
TABLE 56 Rest of North America Rabeprazole Sodium Market by Distribution Channel, 2024 - 2031, USD Thousands
TABLE 57 Rest of North America Rabeprazole Sodium Market by Application, 2020 - 2023, USD Thousands
TABLE 58 Rest of North America Rabeprazole Sodium Market by Application, 2024 - 2031, USD Thousands
TABLE 59 Key Information -Cadila Pharmaceutical LimitedXX
TABLE 60 Key Information - Alembic Pharmaceuticals Ltd.
TABLE 61 Key Information - Woodward Pharma Services
TABLE 62 Key Information - Elikem Pharmaceuticals Pvt. Ltd.
TABLE 63 Key Information - Jasco Labs Pvt. Ltd.
TABLE 64 Key Information - Torrent Pharmaceuticals Ltd.
TABLE 65 Key Information - Cipla Limited
TABLE 66 Key Information - Sun Pharmaceutical Industries Ltd.
TABLE 67 Key Information - Intas Pharmaceutical Ltd.
TABLE 68 Key Information - Dr. Reddy's Laboratories Ltd.